비자성 휠체어 시장 규모, 점유율, 동향 분석 보고서 : 환자 체중별, 자장 강도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Non-magnetic Wheelchair Market Size, Share & Trends Analysis Report By Patient Weight, By Magnetic Field Strength, By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,266,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,655,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,434,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

비자성 휠체어 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 비자성 휠체어 세계 시장 규모는 2030년까지 8,870만 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 6.9%의 CAGR을 기록할 것으로 예상됩니다.

이러한 성장의 배경에는 노인 인구의 증가, 생리적 및 신경학적 질환의 부담 증가, 선진국과 개발도상국의 첨단 의료 영상 기술 채택이 있습니다. 다발성 경화증(MS), 파킨슨병(PD), 근위축성 측삭경화증(ALS), 척수손상, 뇌졸중 등 질병은 이동 장애를 유발하고 휠체어의 필요성을 증가시킵니다. 2022년 5월 미국 다발성 경화증 협회의 기사에 따르면, 미국에서는 약 100만 명이 다발성 경화증에 시달리고 있습니다.

노인 인구의 증가는 비자성 휠체어에 대한 수요를 촉진할 것으로 예상되며, OECD가 2021년 발표한 보고서에 따르면 아시아 중저소득 국가의 평균 수명은 2000년 이후 6년, 고소득 국가는 4년이 늘어났다고 합니다. 마찬가지로 세계보건기구(WHO)는 2050년까지 각국 전체에서 약 21억 명이 60세 이상이 될 것으로 추정하고 있습니다.

자기공명영상장치(MRI)와 같은 검진 수단의 채택이 각국에서 진행되고 있는 것은 휠체어 수요를 촉진할 것으로 예상됩니다. 또한, 헬스케어 분야의 민관 파트너십은 시장 참여자들에게 기회를 제공할 것으로 예상됩니다. 예를 들어, 영국 정부는 2023년 8월, 2025년까지 전국에 160개의 진단 센터를 설립하는 것을 목표로 하고 있습니다. 프로젝트 비용은 29억 3,000만 달러로 추정됩니다.

비자성 휠체어 시장 보고서 하이라이트

• 북미는 2023년 34.86%의 매출 점유율을 차지하며 시장을 장악했습니다. 첨단 의료 기술의 존재, 우수한 의료 상환 정책, 질병에 취약한 노인 인구의 증가가 그 요인입니다.
• 2023년 매출 점유율은 47.75%로, 환자 체중 100kg-150kg 카테고리가 시장을 주도했습니다.
• 자장 강도를 기준으로 2023년 3T까지의 부문이 78.79%의 매출 점유율로 우위를 점했습니다.
• 병원 최종 용도 부문은 2023년 51.49%의 매출 점유율로 우위를 점했습니다. 이 압도적인 점유율은 다양한 환자군을 수용하는 병원들이 차지하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 비자성 휠체어 시장 변수, 동향 및 범위

• 시장 계통 전망
• 시장 동향과 전망
• 시장 역학
• 사업 환경 분석

제4장 비자성 휠체어 시장 : 환자 체중 비지니스 분석

• 비자성 휠체어 시장 : 환자 체중 변동과 시장 점유율 분석, 2023년과 2030년
• 100kg 미만
• 100kg-150kg
• 150kg 이상

제5장 비자성 휠체어 시장 : 자장 강도 비지니스 분석

• 비자성 휠체어 시장 : 자장 강도 변동과 시장 점유율 분석, 2023년과 2030년
• 3T 미만
• 7T 미만

제6장 비자성 휠체어 시장 : 최종 용도 비지니스 분석

• 비자성 휠체어 시장 : 최종 용도 변동과 시장 점유율 분석, 2023년과 2030년
• 병원
• 외래 시설

제7장 비자성 휠체어 시장 : 지역 비지니스 분석

• 지역 시장 현황
• 국가별 시장 점유율 분석, 2023년
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 상황

• 기업 분류
• 전략 매핑
• 기업 개요·리스트
  • GF Health Products, Inc.
  • Magmedix Inc.
  • MRIequip.com
  • Newmatic Medical
  • AliMed
  • Innovative Products Unlimited, Inc.
  • Nanning Hhao Technology Co., Ltd
  • Matsunaga
  • Hebei Webian Medical Instrument Co., Ltd
  • Jiangsu Rooe Medical Technology Co., Ltd

ksm

영문 목차

영문목차

Non-magnetic Wheelchair Market Growth & Trends:

The global non-magnetic wheelchair market size is expected to reach USD 88.7 million by 2030 and display a CAGR of 6.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth is attributed to the growing geriatric population, increasing burden of physiological and neurological diseases, and adoption of advanced healthcare imaging technologies in developed and developing countries. Diseases such as multiple sclerosis (MS), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), spinal cord injuries, and stroke lead to mobility impairments, which augments the need for wheelchairs. According to an article by the Multiple Sclerosis Association of America in May 2022, nearly 1 million people in the U.S. suffer from MS.

The growing geriatric population is expected to drive the demand for non-magnetic wheelchairs. According to OECD's report in 2021, the life expectancy in lower- and middle-income Asian countries has increased by six years from 2000, while upper-middle-income countries have recorded a growth of four years in life expectancy. Similarly, the WHO estimates that by 2050, nearly 2.1 billion people across countries will be aged over 60.

Growing adoption of screening modalities such as magnetic resonance imaging (MRI) across countries is expected to drive demand for wheelchairs. In addition, public-private partnership in the healthcare sector is expected to create favorable opportunities for the market players. For instance, in August 2023, the UK government aims to establish 160 diagnostic centers nationwide by 2025. The project cost is estimated at USD 2.93 billion.

Non-magnetic Wheelchair Market Report Highlights:

• North America dominated the market with a revenue share of 34.86% in 2023, attributed to the presence of advanced healthcare technologies, superior healthcare reimbursement policies, and a growing geriatric population susceptible to diseases
• With 47.75% of revenue share in 2023, the 100 kg to 150 kg patient weight category led the market
• Based on field strength, up to 3T segment dominated with a revenue share of 78.79% in 2023
• Hospitals end-use segment dominated with a revenue share of 51.49% in 2023. The dominant share is attributed to hospitals as they cater to a diverse patient population

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
  • 1.5.1. Volume Price Analysis
    • 1.5.1.1. Approach 1: Volume Price Analysis
• 1.6. Data Validation & Publishing
• 1.7. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Non-Magnetic Wheelchair Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing geriatric population
    • 3.3.1.2. Growing prevalence of physiological and neurological diseases
    • 3.3.1.3. Increasing installations of imaging modalities such as magnetic resonance imaging (MRI).
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Stringent regulatory rule for providers
    • 3.3.2.2. High-cost variability across regions and limited manufacturer presence
• 3.4. Business Environment Analysis
  • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
  • 3.4.2. Porter's Five Forces Analysis
  • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Non-Magnetic Wheelchair Market: Patient Weight Business Analysis

• 4.1. Non-Magnetic Wheelchair Market: Patient Weight Movement & Market Share Analysis, 2023 & 2030
• 4.2. Below 100 kg
  • 4.2.1. Below 100 kg Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.3. 100 kg to 150 kg
  • 4.3.1. 100 kg to 150 kg Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Above 150 kg
  • 4.4.1. Above 150 kg Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Non-Magnetic Wheelchair Market: Magnetic Field Strength Business Analysis

• 5.1. Non-Magnetic Wheelchair Market: Magnetic Field Strength Movement & Market Share Analysis, 2023 & 2030
• 5.2. Up to 3T
  • 5.2.1. Up to 3T Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.3. Up to 7T
  • 5.3.1. Up to 7T Non-Magnetic Wheelchair Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Non-Magnetic Wheelchair Market: End-use Business Analysis

• 6.1. Non-Magnetic Wheelchair Market: End-use Movement & Market Share Analysis, 2023 & 2030
• 6.2. Hospitals
  • 6.2.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.3. Outpatient Facilities
  • 6.3.1. Outpatient Facilities Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Non-Magnetic Wheelchair Market: Regional Business Analysis

• 7.1. Regional Market Snapshot
• 7.2. Market Share Analysis by Country, 2023
  • 7.2.1. North America
  • 7.2.2. Europe
  • 7.2.3. Asia Pacific
  • 7.2.4. Latin America
  • 7.2.5. MEA
• 7.3. North America
  • 7.3.1. North America Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. U.S. Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.3.2.2. Key Country Dynamics
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. Regulatory Framework
  • 7.3.3. Canada
    • 7.3.3.1. Canada Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.3.3.2. Key Country Dynamics
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
• 7.4. Europe
  • 7.4.1. Europe Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Germany Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.4.2.2. Key Country Dynamics
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Regulatory Framework
  • 7.4.3. UK
    • 7.4.3.1. UK Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.4.3.2. Key Country Dynamics
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
  • 7.4.4. France
    • 7.4.4.1. France Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.4.4.2. Key Country Dynamics
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
  • 7.4.5. Italy
    • 7.4.5.1. Italy Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.4.5.2. Key Country Dynamics
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
  • 7.4.6. Spain
    • 7.4.6.1. Spain Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.4.6.2. Key Country Dynamics
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
  • 7.4.7. Denmark
    • 7.4.7.1. Denmark Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.4.7.2. Key Country Dynamics
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
  • 7.4.8. Sweden
    • 7.4.8.1. Sweden Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.4.8.2. Key Country Dynamics
    • 7.4.8.3. Competitive Scenario
    • 7.4.8.4. Regulatory Framework
  • 7.4.9. Norway
    • 7.4.9.1. Norway Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.4.9.2. Key Country Dynamics
    • 7.4.9.3. Competitive Scenario
    • 7.4.9.4. Regulatory Framework
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Japan Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.5.2.2. Key Country Dynamics
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Regulatory Framework
  • 7.5.3. China
    • 7.5.3.1. China Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.5.3.2. Key Country Dynamics
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
  • 7.5.4. India
    • 7.5.4.1. India Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.5.4.2. Key Country Dynamics
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Regulatory Framework
  • 7.5.5. South Korea
    • 7.5.5.1. South Korea Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.5.5.2. Key Country Dynamics
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Regulatory Framework
  • 7.5.6. Australia
    • 7.5.6.1. Australia Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.5.6.2. Key Country Dynamics
    • 7.5.6.3. Competitive Scenario
    • 7.5.6.4. Regulatory Framework
  • 7.5.7. Thailand
    • 7.5.7.1. Thailand Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.5.7.2. Key Country Dynamics
    • 7.5.7.3. Competitive Scenario
    • 7.5.7.4. Regulatory Framework
• 7.6. Latin America
  • 7.6.1. Latin America Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Brazil Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.6.2.2. Key Country Dynamics
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Regulatory Framework
  • 7.6.3. Mexico
    • 7.6.3.1. Mexico Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.6.3.2. Key Country Dynamics
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
  • 7.6.4. Argentina
    • 7.6.4.1. Argentina Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.6.4.2. Key Country Dynamics
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Regulatory Framework
• 7.7. MEA
  • 7.7.1. MEA Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. South Africa Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.7.2.2. Key Country Dynamics
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. Regulatory Framework
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Saudi Arabia Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.7.3.2. Key Country Dynamics
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. Regulatory Framework
  • 7.7.4. UAE
    • 7.7.4.1. UAE Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.7.4.2. Key Country Dynamics
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Regulatory Framework
  • 7.7.5. Kuwait
    • 7.7.5.1. Kuwait Non-Magnetic Wheelchair Market, 2018 - 2030 (USD Million)
    • 7.7.5.2. Key Country Dynamics
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. Regulatory Framework

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Profiles/Listing
  • 8.3.1. GF Health Products, Inc.
    • 8.3.1.1. Overview
    • 8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.1.3. Product Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Magmedix Inc.
    • 8.3.2.1. Overview
    • 8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.2.3. Product Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. MRIequip.com
    • 8.3.3.1. Overview
    • 8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.3.3. Product Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Newmatic Medical
    • 8.3.4.1. Overview
    • 8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.4.3. Product Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. AliMed
    • 8.3.5.1. Overview
    • 8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.5.3. Product Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Innovative Products Unlimited, Inc.
    • 8.3.6.1. Overview
    • 8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.6.3. Product Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Nanning Hhao Technology Co., Ltd
    • 8.3.7.1. Overview
    • 8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Matsunaga
    • 8.3.8.1. Overview
    • 8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Hebei Webian Medical Instrument Co., Ltd
    • 8.3.9.1. Overview
    • 8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Jiangsu Rooe Medical Technology Co., Ltd
    • 8.3.10.1. Overview
    • 8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives

관련자료